Considering that BChE is overexpressed during the course of AD and plays a rather prominent role over AChE [76], it was investigated if the merging approach could deliver MTDLs able to target 5-HT6R, BChE, and β-amyloid aggregation. The gene discussed is BCHE; the disease is Alzheimer disease.